APP下载

两种静脉途径在直肠癌患者FolFox4化疗方案中的应用

2017-05-11尚静王锐

中国医药导报 2017年8期
关键词:改善

尚静+王锐

[摘要] 目的 探讨两种静脉途径在直肠癌患者FolFox4化疗方案中的应用效果。 方法 分析陕西省榆林市第二医院2014年5月~2016年6月收治的170例直肠癌手术患者临床资料,依据静脉途径不同进行分组,治疗Ⅰ组(PICC置管)80例和治疗Ⅱ组(浅静脉留置针)90例。观察两组直肠癌患者静脉损伤、临床效果、生活质量改善、静脉输液疼痛评分情况。 结果 治疗Ⅰ组直肠癌患者静脉损伤程度分级优于治疗Ⅱ组(P < 0.05),治疗Ⅰ组直肠癌患者临床治疗总缓解率和生活质量改善情况高于治疗Ⅱ组(P < 0.05),治疗Ⅰ组直肠癌患者静脉输液疼痛评分低于治疗Ⅱ组(P < 0.05)。 结论 在直肠癌患者中应用PICC置管联合便携式化疗泵,可以明显降低患者静脉损伤程度,提高患者临床疗效和生活质量,降低静脉输液疼痛,值得临床推广应用。

[关键词] 静脉途径;直肠癌;FolFox4化疗方案;缓解;改善;疼痛

[中图分类号] R47 [文献标识码] A [文章编号] 1673-7210(2017)03(b)-0167-04

The application of patients with rectal carcinoma underwent the FolFox4 chemotherapy protocol by two intravenous route

SHANG Jing WANG Rui

The First Ward, Department of General Surgery, the Second Hospital of Yulin City, Shaanxi Province, Yulin 719000, China

[Abstract] Objective To approach the application of patients with rectal carcinoma underwent the FolFox4 chemotherapy protocol by two intravenous route. Methods 170 patients with rectal carcinoma in the Second Hospital of Yulin City from May 2014 to June 2016 were selected and divided into two groups by vein approach, with 80 cases in treatmentⅠgroup (PICC cannulation) and 90 cases in treatmentⅡgroup (superficial vein catheter). The venous injury, clinical effect, life quality improvement, intravenous infusion pain score of two groups were compared. Results The vein injury grade of treatment I group was better than that of treatmentⅡgroup (P < 0.05). The total remission rate of clinical treatment and life quality improvement of treatmentⅠgroup were higher than that of treatmentⅡgroup (P < 0.05). The intravenous infusion pain score of treatmentⅠgroup was lower than that of treatmentⅡgroup (P < 0.05). Conclusion The application of PICC cannulation compared with portable chemotherapy pump in patients with rectal carcinoma, which can decrease vein injury grade, increase clinical effect and life quality, and decrease venous transfusion pain. It is worthy of clinical application.

[Key words] Intravenous route; Rectal carcinoma; FolFox4 chemotherapy protocol; Remission;Improvement; Pain

直肠癌是人体常见的消化道恶性肿瘤,近年来直肠癌发生率呈现明显升高趋势,成为危害人类身心健康的重要疾病。随着直肠癌新辅助治疗方法的更新和进步,化疗作为有效的治疗方法,在临床得到广泛应用[1-2]。静脉化疗是临床上常用的治疗直肠癌的给药途径,其可以促使癌灶缩小,降低恶性程度,在一定程度上提高手术根治性切除率及保肛率,但是其引起的不良反应也较多,会影响有效率[3-4]。本研究通过对陕西省榆林市第二医院(以下简称“我院”)收治的170例直肠癌患者临床资料进行分析,拟探讨不同静脉途径在直肠癌患者FolFox4化疗方案中的应用效果,为提高晚期直肠癌手術根治切除率和保肛率,提供可靠的理论依据。结果报道如下:

1 资料与方法

1.1 临床资料

选取我院2014年5月~2016年6月收治的170例直肠癌手术患者作为本次研究对象,依据静脉途径不同进行分组。治疗Ⅰ组80例,男42例,女38例,年龄54~81岁,平均(65.2±10.3)岁;……

登录APP查看全文

猜你喜欢

改善
成武县生态环境现状与思考
依托民间游戏提高学生身心素质研究
新时期高校教师思想政治观探析
浅析当前中职学校英语教学存在的不足及改善措施
高校财务内部控制问题及改善措施初探
城市道路下穿立交排水设计研究
徐州市云龙湖健步走运动的调查分析
基于IOWHA法的物流需求组合改善与预测模型构建